TrialHerz1998

[Pharmacoeconomic evaluation of pravastatin in the secondary prevention of coronary heart disease in patients with average cholesterol levels. An analysis for Germany based on the CARE study].

T D Szucs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.